Tweet
First Trust Advisors LP lowered its position in shares of LifePoint Health Inc (NASDAQ:LPNT) by 12.1% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 434,659 shares of the company's stock after selling 59,871 shares during the period. First Trust Advisors LP owned approximately 1.12% of LifePoint Health worth $21,211,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Point72 Asia Hong Kong Ltd raised its stake in shares of LifePoint Health by 1,897.5% during the first quarter. Point72 Asia Hong Kong Ltd now owns 2,417 shares of the company's stock valued at $114,000 after purchasing an additional 2,296 shares during the period. Bank of Montreal Can purchased a new stake in shares of LifePoint Health during the second quarter valued at approximately $169,000. Campbell & CO Investment Adviser LLC purchased a new stake in shares of LifePoint Health during the second quarter valued at approximately $211,000. Verition Fund Management LLC purchased a new stake in shares of LifePoint Health during the first quarter valued at approximately $224,000. Finally, Alambic Investment Management L.P. purchased a new stake in shares of LifePoint Health during the first quarter valued at approximately $240,000. Get LifePoint Health alerts:
Shares of NASDAQ:LPNT opened at $64.50 on Friday. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.85 and a quick ratio of 1.63. The firm has a market capitalization of $2.50 billion, a P/E ratio of 17.77, a P/E/G ratio of 1.34 and a beta of 0.71. LifePoint Health Inc has a 12-month low of $41.45 and a 12-month high of $65.35.
LifePoint Health (NASDAQ:LPNT) last issued its quarterly earnings results on Friday, July 27th. The company reported $1.27 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.08 by $0.19. The business had revenue of $1.57 billion during the quarter, compared to analyst estimates of $1.58 billion. LifePoint Health had a net margin of 0.65% and a return on equity of 7.04%. The business's revenue was down 1.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.96 earnings per share. equities research analysts predict that LifePoint Health Inc will post 4.59 earnings per share for the current year.
LPNT has been the topic of a number of analyst reports. ValuEngine lowered shares of LifePoint Health from a "sell" rating to a "strong sell" rating in a research note on Wednesday, May 2nd. BidaskClub upgraded shares of LifePoint Health from a "buy" rating to a "strong-buy" rating in a research note on Friday, May 4th. SunTrust Banks reiterated a "hold" rating and set a $58.00 price objective on shares of LifePoint Health in a research note on Monday, May 7th. Zacks Investment Research upgraded shares of LifePoint Health from a "hold" rating to a "buy" rating and set a $55.00 price objective on the stock in a research note on Wednesday, July 4th. Finally, Raymond James lowered shares of LifePoint Health from an "outperform" rating to a "market perform" rating in a research note on Monday, July 23rd. Three research analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have issued a buy rating to the company. The stock has a consensus rating of "Hold" and a consensus target price of $58.73.
LifePoint Health Company Profile
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the United States. Its hospitals provide a range of medical and surgical services, such as general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation, and pediatric, as well as specialized services, including open-heart surgery, skilled nursing, psychiatric care, and neuro-surgery